Chronical haloperidol and clozapine treatment in rats: Differential RNA display analysis, behavioral studies and serum level determination

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 7, 1998, Pages 1129-1139

  Fischer, Viola ^a   Schmitt, Ulrich ^a   Weigmann, Harald ^a   Keller, Boris V ^a   Reuss, Stefan ^a   Hiemke, Christoph ^a   Dahmen, Norbert ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Behavioral studies; Chronical treatment; Clozapine; Differential RNA display; Haloperidol

Indexed keywords

CLOZAPINE; HALOPERIDOL; RNA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GENE ISOLATION; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; ORAL DRUG ADMINISTRATION; RAT; RNA ANALYSIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; DNA PRIMERS; FEMALE; HALOPERIDOL; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0032190858     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00065-7     Document Type: Article

References (30)

1. BALDESSARINI, R. J., CENTORRINO, F., FLOOD, J. G., VOLPICELLI, S. A., HUSTON-LYONS, D. and COHEN, B. M. (1993) Tissue Concentrations of Clozapine and its Metabolites in the Rat. Neuropsychopharmacol. 9: 117-124.
2. BARTHOLINI, G. (1976) Differential Effects of Neuroleptic Drugs on Dopamine Turnover in the Extrapyramidal and Limbic Systems. J. Pharm. Pharmacol. 28: 429-433.
3. BAUER, P., MÜLLER, H., REICH, J., RIEDL, H., AHRENKIEL, V., WARTHOE, P. and STRAUSS, M. (1993) Identification of Differentially Expressed mRNA Species by an Improved Display Technique (DDRT-PCR). Nuc. Acid. Res. 21: 4272-4280.
4. BRUHWYLER, J., CHLEIDE, E., LIEGEOIS, J. F., DELARGE, J. and MERCIER, M. (1990) Anxiolytic Potential of Sulpiride, Clozapine and Derivates in the Open-Field Test. Pharmacol. Biochem. Behav. 36: 57-61.
5. CHOMCZYNSKI, P. and SACCHI, N. (1987) Single-Step of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction. Ana. Biochem. 162: 156-159.
6. HASEGAWA, M., GUTIERREZ-ESTEINOU, R., WAY, L. and MELTZER, H. Y. (1993) Relationship Between Clinical Efficacy and Clozapine Concentrations in Plasma in Schizophrenia: Effect of Smoking. J. Clin. Psychopharmacol. 13: 383-390.
7. JANSSEN, P. A. J., VAN DE WESTERINGH, C., JAGENAU, A. H. M., DEMOEN, P. A. J., HERMANS, B. K. F., VAN DAELE, G. H. P., SCHELLEKENS, K. H. L., VAN DER EYCKEN, C. A. M. and NIEMEGEERS, C. J. E. (1959) Chemistry and Pharmacology of CNS Depressants Related to 4-(4-Hydroxy-4-Phenylpiperidino)-Butyrophenone, Part 1 - Synthesis Acid Screening Data in Mice. J. Med. Pharm. Chem. 1: 281-297.
8. KERWIN, R. W. (1994) The New Atypical Antipsychotics. British J. Psychiat. 164: 141-148.
9. LEYSEN, J. E., JANSSEN, P., GOMMEREN, W., WYNANTS, J., PAUWELS, P. J. and JANSSEN, P. A. J. (1992) In Vitro and In Vivo Binding and Effects on Monoamine Turnover in Rat Brain Regions of the Novel Antipsychotics Risperidone and Ocaperidone. Mol. Pharmacol. 41: 494-508.
10. LIANG, P. and PARDEE, A. B. (1992) Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction. Science 257: 967-971.
11. LIANG, P., AVERBOUKH, L. and PARDEE, A. B. (1993) Distribution and Cloning of Eukaryotic mRNAs by Means of Differential Dislay: Refinements and Optimization. Nuc. Acid. Res. 21: 3269-3275.
12. MAC GIBBON, G. A., LAWLOR, P. A., BRAVO, R. and DRAGUNOW, M. (1994) Clozapine and Haloperidol Produce a Differential Pattern of Immediate Early Gene Expression in Rat Caudate-Putamen, Nucleus Accumbens, Lateral Septum and Islands of Calleja. Mol. Brain Res. 23: 21-32.
13. MARIN, C., ENGBER, T. M., BONASTRE, M., CHASE, T. N. and TOLOSA, T. (1996) Effect of Long-Term Haloperidol Treatment on Striatal Neuropeptides: Relation to Stereotyped Behavior. Brain Res. 731: 57-62.
14. MEADOR-WOODRUFF, J. H., KING, R. E., DAMASK, S. P. and BOVENKERK, K. A. (1996) Differential Regulation of Hippocampal AMPA and Kainate Receptor Subunit Expression by Haloperidol and Clozapine. Mol. Psychiat. 1: 41-53.
15. NESTLER, E. J. (1997) Images in Neuroscience. Molecular Biology, IV. Identifying DNA Transcription Factors. Am. J. Psychiat. 154: 146.
16. NIELSEN, E. B. and Andersen P. H. (1992) Dopamine Receptor Occupancy in Vivo: Behavioral Correlates Using NNC-112, NNC-687 and NNC-756, New Selective Dopamine D1 Receptor Antagonists. Eur. J. Pharmacol. 219: 35-44.
17. OLIVIER, B., MOS, J. and RASMUSSEN, D. (1990) Behavioural Pharmacology of the Serenic, Eltoprazine. Drug Metabol. Drug Interact. 8: 31-83.
18. PEARSON, W. R. and LIPMAN D. J. (1988) Improved Tools for Biological Sequence Comparison. Proc. Natl. Acad. Sci. USA 85: 2444-2448.
19. PAULUS, M. P. and GEYER, M. A. (1991) A Scaling Approach to Find Order Parameters Quantifying the Effects of Dopaminergic Agents on Unconditioned Motor Activity in Rats. Prog. Neuropsychopharmacol. Biol. Psychiat. 15: 903-919.
20. PERRY, P. J., MILLER, D. D., ARNDT, S. V. and CADORET, R. J. (1991) Clozapine and Norclozapine Plasma Concentrations and Clinical Response of Treatment-Refractory Schizophrenic Patients. Am. J. Psychiat. 148: 233-235.
21. PILOWSKY, L. S., COSTA, D. C., ELL, P. J., MURRAY, R. M., VERHOEFF, N. P. and KERWIN, R. W. (1992) Clozapine, Single Photon Emission Tomography, and the D2 Dopamine Receptor Blockade Hypothesis of Schizophrenia. Lancet 340: 199-202.
22. RAO, M. L. (1986) Modification of the Radioreceptor Assay Technique for Estimation of Serum Neuroleptic Drug Levels Leads to Improved Precision and Sensitivity. Psychopharmacol. 90: 548-553.
23. ROBERTSON, G. S. and FIBIGER, H. C. (1992) Neuroleptics Increase c-fos Expression in the Forebrain: Contrasting Effects of Haloperidol and Clozapine. Neurosci. 46: 315-328.
24. SETTLE, E. C. Jr. and AYD F. J. Jr. (1983) Haloperidol: A Quarter Century of Experience. J. Clin. Psychiat. 44: 440-448.
25. VAN DEN BUUSE, M. and DE JONG, W. (1989) Differential Effects of Dopaminergic Drugs on Open-Field Behavior of Spontaneously Hypersensitive Rats and Normotensive Wistar-Kyoto Rats. J. Pharmacol. Exp. Ther. 248: 1189-1196.
26. VAN PUTTEN, T., MARDER, S. R., MINTZ, J. and POLAND, R. E. (1992) Haloperidol Plasma Levels and Clinical Response: A Therapeutic Window Relationship. Am. J. Psychiat. 149: 500-505.
27. VAN TOL, H. H., BRUNZOW, J. R., GUAN, H. C., SUNAHARA, R. K., SEEMAN, P., NIZNIK, H. B. and CIVELLI, O. (1991) Cloning of the Gene for a Human Dopamine D4 Receptor with High Affinity for the Antipsychotic Clozapine. Nature 350: 610-614.
28. WATERS, S. M., KONOKOY, C. S. and DAVIS, T. P. (1996) Haloperidol and Apomorphine Differentially Affect Neuropeptidase Activity. J. Pharmacol. Exp. Ther. 277: 113-120.
29. WEIGMANN, H., BIERBRAUER, J., HÄRTTER, S. and HIEMKE, C. (1997) Automated Determination of Clozapine and Major Metabolites in Serum and Urine. Therap. Drug Monit. 19: 480-488.
30. WEINER, I., SHADACH, E., TARRASCH, R., KIDRON, R. and FELDON, J. (1996) The Latent Inhibition Model of Schizophrenia: Further Validation Using the Atypical Neuroleptic, Clozapine. Biol. Psychiat. 40: 834-843.